Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis
European Journal of Endocrinology · 03.01.2024 · 190 (1) · S1-S11
DOI: 10.1093/ejendo/lvad166 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Endocrinology, online erschienen am 21.12.2023. Verfasst von Emma C Alexander und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, …. Hauptthemen laut MEDLINE: Hypogonadism, Klinefelter Syndrome. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIHR Academic Clinical Fellowship, NIHR.
Abstract (Originalsprache)
Objective
Hypogonadotropic hypogonadism is characterized by inadequate secretion of pituitary gonadotropins, leading to absent, partial, or arrested puberty. In males, classical treatment with testosterone promotes virilization but not testicular growth or spermatogenesis. To quantify treatment practices and efficacy, we systematically reviewed all studies investigating gonadotropins for the achievement of pubertal outcomes in males with hypogonadotropic hypogonadism.
Design
Systematic review and meta-analysis.
Methods
A systematic review of Medline, Embase, Global Health, and PsycINFO databases in December 2022. Risk of Bias 2.0/Risk Of Bias In Non-randomized Studies of Interventions/National Heart, Lung, and Blood Institute tools for quality appraisal. Protocol registered on PROSPERO (CRD42022381713).
Results
After screening 3925 abstracts, 103 studies were identified including 5328 patients from 21 countries. The average age of participants was <25 years in 45.6% (n = 47) of studies. Studies utilized human chorionic gonadotropin (hCG) (n = 93, 90.3% of studies), human menopausal gonadotropin (n = 42, 40.8%), follicle-stimulating hormone (FSH) (n = 37, 35.9%), and gonadotropin-releasing hormone (28.2% n = 29). The median reported duration of treatment/follow-up was 18 months (interquartile range 10.5-24 months). Gonadotropins induced significant increases in testicular volume, penile size, and testosterone in over 98% of analyses. Spermatogenesis rates were higher with hCG + FSH (86%, 95% confidence interval [CI] 82%-91%) as compared with hCG alone (40%, 95% CI 25%-56%). However, study heterogeneity and treatment variability were high.
Conclusions
This systematic review provides convincing evidence of the efficacy of gonadotropins for pubertal induction. However, there remains substantial heterogeneity in treatment choice, dose, duration, and outcomes assessed. Formal guidelines and randomized studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
- Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom.
- Department of Paediatric Endocrinology, Great Ormond Street Hospital NHS Trust, London WC1N 3JH, United Kingdom.
- Department of Paediatric Endocrinology, Royal London Children's Hospital, Barts Health NHS Trust, London E1 1BB, United Kingdom.
ORCID-Profile: Kyla Ng Yin, Sasha R Howard
Förderung
- Wellcome Trust
- NIHR Academic Clinical Fellowship
- NIHR
- NHS
- UK Department of Health and Social Care
- Barts Charity
Zitieren
APA
Alexander, E. C., Faruqi, D., Farquhar, R., Unadkat, A., Ng Yin, K., Hoskyns, R., Varughese, R., & Howard, S. R. (2024). Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis. European Journal of Endocrinology, 190(1), S1-S11. https://doi.org/10.1093/ejendo/lvad166
Vancouver
Alexander EC, Faruqi D, Farquhar R, Unadkat A, Ng Yin K, Hoskyns R, et al. Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis. European Journal of Endocrinology. 2024;190(1):S1-S11. doi:10.1093/ejendo/lvad166
BibTeX
@article{Alexander2024,
author = {Alexander, Emma C and Faruqi, Duaa and Farquhar, Robert and Unadkat, Ayesha and Ng Yin, Kyla and Hoskyns, Rebecca and Varughese, Rachel and Howard, Sasha R},
title = {Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis},
journal = {European Journal of Endocrinology},
year = {2024},
volume = {190},
number = {1},
pages = {S1--S11},
doi = {10.1093/ejendo/lvad166}
}
EUVIMED